Critical role for D‐type cyclins in cellular transformation induced by E6/E7 of human papillomavirus type 16 and E6/E7/ErbB‐2 cooperation
- 8 May 2007
- journal article
- carcinogenesis
- Published by Wiley in Cancer Science
- Vol. 98 (7) , 973-977
Abstract
Recently, we reported that E6/E7 of human papillomavirus (HPV) type 16 cooperates with the ErbB‐2 receptor to induce cellular transformation of human normal oral epithelial (NOE) and mouse normal embryonic fibroblast (NEF) cells. Furthermore, we demonstrated that cyclin D1 is essential for this transformation induced by E6/E7 and E6/E7/ErbB‐2 cooperation using cyclin D1 antisense and knockout (D1−/–) cells. To determine the role of all D‐type cyclins (D1, D2 and D3) in E6/E7/ErbB‐2 cooperation, we examined the effects of E6/E7, ErbB‐2 alone and E6/E7/ErbB‐2 together in NEF, NEF‐D1−/–, NEF‐D2−/– and NEF‐D3−/– cells. We confirm that NEF‐E6/E7 and NEF‐E6/E7/ErbB‐2, but not NEF‐ErbB‐2 cells, induce colony formation in soft agar and tumor formation in nude mice. We report that E6/E7, ErbB‐2 and E6/E7/ErbB‐2 together all fail to induce neoplastic transformation of D1−/– and D2−/– cells in vitro and in vivo. In contrast, E6/E7/ErbB‐2 together but neither E6/E7 nor ErbB‐2 alone provoke cellular transformation of D3−/– cells. Nevertheless, D3−/–E6/E7/ErbB‐2 cells resulted in up to a 60 and 50% decrease in colony and tumor formation in soft agar and nude mice, respectively, compared with NEF‐E6/E7/ErbB‐2 cells. Furthermore, using cyclin D2 small interfering RNA we inhibited tumor and colony formation of the human NOE‐E6/E7‐ErbB‐2‐transformed cell line; in contrast, cyclin D3 small interfering RNA repressed approximately 50% of colony and 40% of tumor formation of E6/E7/ErbB‐2 cooperation in this cell line. These data suggest that cyclins D1, D2 and D3 (to a lesser extent) are important downstream mediators of the cellular transformation induced by E6/E7 and E6/E7/ErbB‐2 cooperation in normal cells. Our data imply that anti‐D‐type cyclin therapies are important in the treatment of human cancers expressing high‐risk HPV or HPV/ErbB‐2. (Cancer Sci 2007; 98: 973–977)Keywords
This publication has 24 references indexed in Scilit:
- The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical PracticeJNCI: Journal of the National Cancer Institute, 2005
- Elevated serum levels of a c‐erbB‐2 oncogene product in oral squamous cell carcinoma patientsJournal of Oral Pathology & Medicine, 2004
- Frequent overexpression of multiple ErbB receptors by head and neck squamous cell carcinoma contrasts with rare antibody immunity in patientsThe Journal of Pathology, 2004
- Prognostic significance of c-erbB-2/HER2 expression in advanced uterine cervical carcinoma with para-aortic lymph node metastasis treated with radiation therapyInternational Journal of Gynecological Cancer, 2003
- The p53 network in head and neck cancerOral Oncology, 2003
- Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysisBritish Journal of Cancer, 2003
- Expression of Vascular Endothelial Growth Factor in Adenocarcinomas of the Uterine Cervix and Its Relation to Angiogenesis and p53 and c-erbB-2 Protein ExpressionGynecologic Oncology, 2002
- Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control studyThe Lancet, 2002
- Alteration of cyclin D1 and CDK4 gene in carcinoma of uterine cervixCancer Letters, 2001
- Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck CancersJNCI: Journal of the National Cancer Institute, 2000